Skip to main content
EPSCoR/IDeA Coalition
BIOMEDICAL RESEARCH

NIH-Funded Study: Symptom-Based Approach Treats Opioid Withdrawal in Newborns

An NIH-funded clinical study shows that a symptom-based treatment for babies with neonatal opioid withdrawal syndrome (NOWS) could speed up their recovery with minimal drug exposure.

An NIH-funded clinical study shows that a symptom-based treatment for babies with neonatal opioid withdrawal syndrome (NOWS) — a highly prevalent condition wherein opioid exposure during pregnancy leads to withdrawal after birth — could speed up their recovery.

The approach reduces reliance on pharmacological intervention, potentially improving outcomes for affected newborns and their families.

National coordination, local impact.

EPSCoR and IDeA programs operate in 25 states and 3 territories. Each state has a dedicated program office coordinating research investments, workforce development, and federal partnerships.